2019 Symposium: Regional Approaches to the Development and Use of Real-World Data and Evidence

Registration is closed. Thank you for your overwhelming support.

Health systems, providers, patients, payers, and regulators around the globe are actively exploring how best to utilise the increasing amounts of real-world data (RWD) and real-world evidence (RWE) that can be actively generated during routine care. This symposium, hosted by the Duke-NUS Centre of Regulatory Excellence and Duke University’s Robert J. Margolis, MD, Center for Health Policy, will convene thought leaders to discuss their efforts to harness RWD and RWE for a range of purposes. A particular focus of the discussion will be on the potential regulatory acceptability of these sources of evidence. An opening presentation from Duke-Margolis will provide a high-level overview of the major challenges in this space, followed by sharing of perspectives from global experts and questions from the audience.



Registration Fee: $50

Due to the limited availability of seats, early registration is strongly recommended.   

Date and Time

23 Sep 2019 @ 15:00 - 23 Sep 2019 @ 17:30


Registration is closed


Mark McClellan_core

Prof Mark McClellan

Professor of Business, Medicine and Policy
Duke-Margolis Center for Health Policy
Duke University

Kelvin Bryan Tan

A/Prof Kelvin Bryan Tan

Policy, Research and Evaluation Division
Ministry of Health
Adjunct Associate Professor
Centre of Regulatory Excellence
Duke-NUS Medical School

James Yip

A/Prof James Yip

Group Chief Medical Information Officer 
National University Health System
Chief Data Advisor
Ministry of Health

Bart Barefoot

Mr Bart Barefoot

Value Evidence & Outcomes and Real-World Evidence Policy, Advocacy, and External Collaboration

Sally Soh

Ms Sally Soh

Regulatory Consultant
Vigilance and Compliance Branch
Health Products Regulation Group
Health Sciences Authority